Geron Corporation Stock News

Here's why penny stocks climb in price The post What Makes Penny Stocks Move? 3 Major Factors to Consider appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

2022 was a terrible year for us biotech investors. We wanted 2023 to be good, and one of the most difficult stocks out there, Geron Corporation, has paid off today.

Though the major indices posted a strong recovery effort on Wednesday, late-stage clinical biopharmaceutical firm Geron (NASDAQ: GERN ) soared above most public players. Following positive top-line re

Hot penny stocks to watch with news this week. The post 7 Top Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

FOSTER CITY, Calif.--( BUSINESS WIRE )--Geron Corporation (Nasdaq: GERN) today announced that it will host a conference call to discuss top-line results from the IMerge Phase 3 clinical trial of imete

Geron Corporation (NASDAQ:GERN ) Q3 2022 Results Conference Call November 3, 2022 9:00 AM ET Company Participants Aron Feingold - Vice President of Investor Relations and Corporate Communications John

Penny stocks to watch this week with news. The post 5 Top Penny Stocks To Watch With News Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

FOSTER CITY, Calif.

Here is how Geron (GERN) and Kiniksa Pharmaceuticals, Ltd. (KNSA) have performed compared to their sector so far this year.

A new White House program will likely boost the entire biotech industry. And it makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

100% technical buy signals. 7 new highs and up 23.83% in the last month.

Penny stocks for your September watch list. The post 4 Penny Stocks To Watch For September 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The company said it expects to submit a new drug application for its lead candidate early next year.

J&J (JNJ) will stop selling its talcum-based baby powder globally from next year. Though reports claim that the use of the talc causes cancer, JNJ maintains its stance that this product is safe.

Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading. Piper Sandler lowered the price target on Olo Inc.